Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

• Ignacio Ortea,

  Current address: Maimónides Health Research Institute (IMIBIC), Córdoba, Spain

  Affiliation Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

  ⨯
• Bernd Roschitzki,

  Affiliation Functional Genomics Center Zurich, University and ETH Zurich, Switzerland

  ⨯
• Rosario López-Rodríguez,

  Affiliation Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

  ⨯
• Eva G. Tomero,

  Affiliation Rheumatology Unit, Hospital Universitario de La Princesa, Instituto Investigacion Sanitaria Princesa, Madrid, Spain

  ⨯
• Juan G. Ovalles,

  Affiliation Rheumatology Unit, Hospital General Universitario Gregorio Marañon, Madrid, Spain

  ⨯
• Javier López-Longo,

  Affiliation Rheumatology Unit, Hospital General Universitario Gregorio Marañon, Madrid, Spain

  ⨯
• Inmaculada de la Torre,

  Affiliation Rheumatology Unit, Hospital General Universitario Gregorio Marañon, Madrid, Spain

  ⨯
• Isidoro González-Alvaro,

  Affiliation Rheumatology Unit, Hospital Universitario de La Princesa, Instituto Investigacion Sanitaria Princesa, Madrid, Spain

  ⨯
• Juan J. Gómez-Reino,

  Affiliations Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain, Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain

  ⨯
• Antonio González

  * E-mail: agmartinezp@ser.es

  Affiliation Laboratorio Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

  ⨯